Prevalence and Some Possible Mechanisms of Colistin Resistance Among Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa

References

• Gad GF, El-Domany RA, Zaki S, Ashour HM. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. J Antimicrob Chemother. 2007;60(5):1010–1017. doi:10.1093/jac/dkm34817906321
   PubMed Web of Science ®Google Scholar
• Farhan SM, Ibrahim RA, Mahran KM, Hetta HF, El-Baky RMA. Antimicrobial resistance pattern and molecular genetic distribution of metallo-β-lactamases producing Pseudomonas aeruginosa isolated from hospitals in Minia, Egypt. Infect Drug Resist. 2019;12:2125. doi:10.2147/IDR.S19837331406468
   PubMed Web of Science ®Google Scholar
• El-Mokhtar MA, Hetta HF. Ambulance vehicles as a source of multidrug-resistant infections: a multicenter study in Assiut City, Egypt. Infect Drug Resist. 2018;11:587. doi:10.2147/IDR.S15178329731647
   PubMed Web of Science ®Google Scholar
• Hosseininassab Nodoushan SA, Yadegari S, Moghim S, et al. Distribution of the strains of multidrug-resistant, extensively drug-resistant, and pandrug-resistant pseudomonas aeruginosa isolates from burn patients. Adv Biomed Res. 2017;6:74. doi:10.4103/abr.abr_239_1628706882
   PubMedGoogle Scholar
• Baron S, Hadjadj L, Rolain JM, Olaitan AO. Molecular mechanisms of polymyxin resistance: knowns and unknowns. Int J Antimicrob Agents. 2016;48(6):583–591. doi:10.1016/j.ijantimicag.2016.06.02327524102
   PubMed Web of Science ®Google Scholar
• Al-Kadmy IM, Ibrahim SA, Al-Saryi N, Aziz SN, Besinis A, Hetta HF. Prevalence of genes involved in colistin resistance in acinetobacter baumannii: first report from Iraq. Microb Drug Resist. 2019. doi:10.1089/mdr.2019.0243
   Web of Science ®Google Scholar
• Wanty C, Anandan A, Piek S, et al. The structure of the neisserial lipooligosaccharide phosphoethanolamine transferase A (LptA) required for resistance to polymyxin. J Mol Biol. 2013;425(18):3389–3402. doi:10.1016/j.jmb.2013.06.02923810904
   PubMed Web of Science ®Google Scholar
• Cannatelli A, D’Andrea MM, Giani T, et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother. 2013;57(11):5521–5526. doi:10.1128/AAC.01480-1323979739
   PubMed Web of Science ®Google Scholar
• Paterson DL, Harris PN. Colistin resistance: a major breach in our last line of defence. Lancet Infect Dis. 2016;16(2):132–133. doi:10.1016/S1473-3099(15)00463-626603171
   PubMed Web of Science ®Google Scholar
• Hasman H, Hammerum AM, Hansen F, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill. 2015;20:49. doi:10.2807/1560-7917.ES.2015.20.49.30085
   Google Scholar
• Zhi C, Lv L, Yu LF, Doi Y, Liu JH. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis. 2016;16(3):292–293. doi:10.1016/S1473-3099(16)00063-326973307
   PubMed Web of Science ®Google Scholar
• Schwarz S, Johnson AP. Transferable resistance to colistin: a new but old threat. J Antimicrob Chemother. 2016;71(8):2066–2070. doi:10.1093/jac/dkw27427342545
   PubMed Web of Science ®Google Scholar
• Ye H, Li Y, Li Z, et al. Diversified mcr-1-harbouring plasmid reservoirs confer resistance to colistin in human gut microbiota. MBio. 2016;7(2):e00177. doi:10.1128/mBio.00177-1627048797
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168. doi:10.1016/S1473-3099(15)00424-726603172
   PubMed Web of Science ®Google Scholar
• Khalifa HO, Ahmed AM, Oreiby AF, Eid AM, Shimamoto T, Shimamoto T. Characterisation of the plasmid-mediated colistin resistance gene mcr-1 in Escherichia coli isolated from animals in Egypt. Int J Antimicrob Agents. 2016;47(5):413–414. doi:10.1016/j.ijantimicag.2016.02.01127112794
   PubMed Web of Science ®Google Scholar
• Fazeli H, Akbari R, Moghim S, Narimani T, Arabestani MR, Ghoddousi AR. Pseudomonas aeruginosa infections in patients, hospital means, and personnel’s specimens. J Res Med Sci. 2012;17(4):332–337.23267393
   PubMed Web of Science ®Google Scholar
• Hudzicki J. Kirby-Bauer Disk Diffusion Susceptibility Test Protocol. 2009.
   Google Scholar
• Wayne P. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. 28th ed. Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163–175. doi:10.1038/nprot.2007.52118274517
   PubMed Web of Science ®Google Scholar
• Machado D, Antunes J, Simoes A, et al. Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolate. J Med Microbiol. 2018;67(6):740–749. doi:10.1099/jmm.0.00074129717972
   PubMed Web of Science ®Google Scholar
• Esposito F, Fernandes MR, Lopes R, et al. Detection of colistin-resistant MCR-1-positive escherichia coli by use of assays based on inhibition by EDTA and zeta potential. J Clin Microbiol. 2017;55(12):3454–3465. doi:10.1128/JCM.00835-1728978685
   PubMed Web of Science ®Google Scholar
• Liu YY, Chandler CE, Leung LM, et al. Structural modification of lipopolysaccharide conferred by mcr-1 in gram-negative ESKAPE pathogens. Antimicrob Agents Chemother. 2017;61:6. doi:10.1128/AAC.00580-17
   Web of Science ®Google Scholar
• Wilson R, Pitt T, Taylor G, et al. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest. 1987;79(1):221–229. doi:10.1172/JCI1127873098783
   PubMed Web of Science ®Google Scholar
• Faraji F, Mahzounieh M, Ebrahimi A, Fallah F, Teymournejad O, Lajevardi B. Molecular detection of virulence genes in Pseudomonas aeruginosa isolated from children with Cystic Fibrosis and burn wounds in Iran. Microb Pathog. 2016;99:1–4. doi:10.1016/j.micpath.2016.07.01327457974
   PubMed Web of Science ®Google Scholar
• Liassine N, Assouvie L, Descombes M-C, et al. Very low prevalence of MCR-1/MCR-2 plasmid-mediated colistin resistance in urinary tract Enterobacteriaceae in Switzerland. Int J Infect Dis. 2016;51:4–5. doi:10.1016/j.ijid.2016.08.00827544715
   PubMed Web of Science ®Google Scholar
• Rebelo AR, Bortolaia V, Kjeldgaard JS, et al. Multiplex PCR for detection of plasmid-mediated colistin resistance determinants, mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 for surveillance purposes. Euro Surveill. 2018;23(6). doi:10.2807/1560-7917.ES.2018.23.6.17-00672
   Google Scholar
• He F, Fu Y, Chen Q, et al. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae. PLoS One. 2015;10(3):e0119064. doi:10.1371/journal.pone.011906425734903
   PubMed Web of Science ®Google Scholar
• Osei Sekyere J, Amoako DG. Carbonyl Cyanide m-Chlorophenylhydrazine (CCCP) reverses resistance to colistin, but not to carbapenems and tigecycline in multidrug-resistant enterobacteriaceae. Front Microbiol. 2017;8:228. doi:10.3389/fmicb.2017.0022828261184
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–685. doi:10.1038/227680a05432063
   PubMed Web of Science ®Google Scholar
• Westphal O, Jann K. Bacterial lipopolysaccharides extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem. 1965;5:83–91.
   Google Scholar
• Davis MR Jr, Goldberg JB. Purification and visualization of lipopolysaccharide from Gram-negative bacteria by hot aqueous-phenol extraction. J Vis Exp. 2012;63:3916.
   Google Scholar
• Ahmed S, Ahmed S, Mohamed W, et al. Nosocomial vancomycin and methicillin resistant staphylococcal infections in intensive care units in Assiut University Hospitals. Egypt J Med Microbiol. 2011;20:2.
   Google Scholar
• Farhan SM, Ibrahim RA, Hetta HF, Mahran KM, Abdelbaky RM. Prevalence of Oxa-23 in Multidrug Resistance Acinetobacter Baumannii Isolated from Different Infections at Minia University Hospital. N. Egypt. J. Microbiol. 2018; 50:34–43.
   Google Scholar
• Abd NE, Abdel-Aleem JA, Abdo MN, Abou-Ghadir OF, Zahran KM, Hetta HF. Efficacy of ketoconazole gel-flakes in treatment of vaginal candidiasis: formulation, in vitro and clinical evaluation. Int J Pharm. 2019;567:118472. doi:10.1016/j.ijpharm.2019.11847231252146
   PubMed Web of Science ®Google Scholar
• Al-Saryi N, Ibrahim SA, AL-Kadmy IM, Hetta HF. Whole genome sequencing of Streptococcus pneumoniae serotype 33C causing fatal sepsis in a hospitalized patient with nephrotic syndrome. Gene Reports. 2019;100434:e2774.
   Google Scholar
• El-Baky RMA, Sandle T, John J, Abuo-Rahma GE-DA, Hetta HF. A novel mechanism of action of ketoconazole: inhibition of the NorA efflux pump system and biofilm formation in multidrug-resistant Staphylococcus aureus. Infect Drug Resist. 2019;12:1703–1718. doi:10.2147/IDR.S20112431354319
   PubMed Web of Science ®Google Scholar
• Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333–1341. doi:10.1086/42932315825037
   PubMed Web of Science ®Google Scholar
• Jeannot K, Bolard A, Plesiat P. Resistance to polymyxins in Gram-negative organisms. Int J Antimicrob Agents. 2017;49(5):526–535. doi:10.1016/j.ijantimicag.2016.11.02928163137
   PubMed Web of Science ®Google Scholar
• Aires CAM, da Conceicao-neto OC, Tavares EOTR, et al. Emergence of the plasmid-mediated mcr-1 gene in clinical KPC-2-producing klebsiella pneumoniae sequence Type 392 in Brazil. Antimicrob Agents Chemother. 2017;61(7). doi:10.1128/AAC.00317-17
   Web of Science ®Google Scholar
• Stojanoski V, Sankaran B, Prasad BVV, Poirel L, Nordmann P, Palzkill T. Structure of the catalytic domain of the colistin resistance enzyme MCR-1. BMC Biol. 2016;14(1):81. doi:10.1186/s12915-016-0303-027655155
   PubMed Web of Science ®Google Scholar
• Hinchliffe P, Yang QE, Portal E, et al. Insights into the mechanistic basis of plasmid-mediated colistin resistance from crystal structures of the catalytic domain of MCR-1. Sci Rep. 2017;7:39392. doi:10.1038/srep3939228059088
   PubMed Web of Science ®Google Scholar
• Sun J, Xu Y, Gao R, et al. Deciphering MCR-2 colistin resistance. MBio. 2017;8(3):e00625–00617. doi:10.1128/mBio.00625-1728487432
   PubMed Web of Science ®Google Scholar
• Marjani MFA, Mohammed NR, Abd SY, Mansour RF. Efflux pumps in colistin resistant pseudomonas aeruginosa isolates in Baghdad. Int J. 2015;3(11):680–685.
   Google Scholar
• Carattoli A, Villa L, Feudi C, et al. Novel plasmid-mediated colistin resistance mcr-4 gene in Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016. Eurosurveillance. 2017;22(31). doi:10.2807/1560-7917.ES.2017.22.31.30589
   Web of Science ®Google Scholar
• Yin W, Li H, Shen Y, et al. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. MBio. 2017;8(3):e00543–00517. doi:10.1128/mBio.00543-1728655818
   PubMed Web of Science ®Google Scholar
• Moffatt JH, Harper M, Harrison P, et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother. 2010;54(12):4971–4977. doi:10.1128/AAC.00834-1020855724
   PubMed Web of Science ®Google Scholar
• Nicas TI, Hancock RE. Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin. J Bacteriol. 1980;143(2):872–878. doi:10.1128/JB.143.2.872-878.19806259125
   PubMed Web of Science ®Google Scholar